A Molecular Genetic Approach to Neuropsychiatric Disease — Some Technical and Ethical Considerations

  • Th. Friedmann
  • F. H. Gage
Conference paper


Most human traits, both normal and pathological, are determined by interactions between genetic and non-genetic environmental factors. Some of the genetic factors are simple, single gene factors whereas many others involve several or possibly many genes interacting with each other as well as with the environment. It is also justified to assume that all normal and pathological functions and characteristics of the human central nervous system, ranging from relatively simple phenotypes to the most complicated of human behaviors, are certain to be as much a combination of genetic and environmental factors as are all other aspects of human biology and disorders of all other organs. It seems evident that a degree of balance between the biological and environmental influences will be found not only to determine behavioral aspects of genetically simple neuropsychiatrie disorders such as Lesch Nyhan syndrome and Huntington’s disease — diseases in which genetic factors almost certainly predominate — but also to contribute in major ways to more complex disorders such as schizophrenia and other affective illnesses in which genetic components have not yet been clearly characterized. Furthermore, it seems inevitable that complicated and probably multiple genetic factors interacting with environmental factors will be associated with degenerative defects such as those responsible for Parkinson’s and Alzheimer’s diseases and other human neurological disorders. Ultimately, aspects of even the most inaccessible and possibly the most unique of human traits — intelligence, memory, cognition, even creativity — must have genetic as well as environmental components.


Central Nervous System Disease Mammalian Central Nervous System Neuropsychiatric Disease Human Trait Molecular Genetic Approach 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Childs B (1970) Sir Archibald Garrod’s conception of chemical individuality: a modern appreciation. N Engl J Med 282:71–77PubMedCrossRefGoogle Scholar
  2. Friedmann T (1989) Progress toward human gene therapy. Science 244:1275–1281PubMedCrossRefGoogle Scholar
  3. Friedmann T (1990) The human genome project — some implications of extensive “reverse genetic” medicine. Am J Hum Genet 46:407–414PubMedGoogle Scholar
  4. Gage FH, Wolff JA, Rosenberg MB, Xu L, Yee J-K, Shults C, Friedmann T (1987) Grafting genetically modified cells to the brain: possibilities for the future. Neuroscience 23:795–807PubMedCrossRefGoogle Scholar
  5. Gusella JF, Wexler NS, Conneally PM, Naylor SL, Anderson MA, Tanzi RE, Watkins PC, Ottina K, Wallace MW, Sakaguchi AY, Young AB, Shoulson I, Bonilla E, Martin JB (1983) A polymorphic DNA marker genetically linked to Huntington’s disease. Nature 306:234–238PubMedCrossRefGoogle Scholar
  6. Kevles DJ (1985) In the name of eugenics. Knopf, New YorkGoogle Scholar
  7. Riordan JR, Rommens JM, Kerem B-S, Alon N, Rozmahel R, Grszelczak Z, Zielenski J, Lok S, Plavsic N, Chou JL, Drumm ML, Iannuzzu MC, Collins FS, Tsui L-C (1989) Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245:1066–1073PubMedCrossRefGoogle Scholar
  8. Rosenberg MB, Friedmann T, Robertson RC, Tuszynski M, Wolff JA, Breakefield XO, Gage FA (1988) Grafting genetically modified cells to the damaged brain: restorative effects of NGF expression. Science 242:1575–1578PubMedCrossRefGoogle Scholar
  9. Sherrington R, Brynjolfsson J, Petursson H, Potter M, Dudleston K, Barraclough B, Wasmuth J, Dobbs M, Gurling H (1988) Localization of a susceptibility locus for schizophrenia on chromosome 5. Nature 336:164–167PubMedCrossRefGoogle Scholar
  10. St George-Hyslop PH, Tanzi RE, Polinsky RJ, Haines JL, Nee L, Watkins PC, Meyers RH, Feldman RG, Pollen D, Drachman D, Growdon J, Bruni A, Foncin JF, Salmon D, Frommelt P, Amaducci L, Sorbi S, Piacentini S, Stewart GD, Hobbs WJ, Conneally PM, Gusella JF (1987) The genetic defect causing familial Alzheimer’s disease maps on chromosome 21. Science 235:885–890PubMedCrossRefGoogle Scholar
  11. Wolff JA, Fisher LJ, Xu L, Jinnah HA, Langlais PJ, Iuovone PM, O’Malley KL, Rosenberg MB, Shimohama S, Friedmann T, Gage FH (1989) Grafting fibroblasts genetically modified to produce L-dopa in a rat model of Parkinson disease. Proc Natl Acad Sci USA 86:9011–9014PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1991

Authors and Affiliations

  • Th. Friedmann
  • F. H. Gage

There are no affiliations available

Personalised recommendations